Teva, GSK Face Another Suit Over Generic Lamictal Deal

Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline LLC were hit Thursday with another proposed class action alleging the companies manipulated a patent settlement to inflate the cost of epilepsy drug Lamictal or...

Already a subscriber? Click here to view full article